Botulinum toxin type A is a potential therapeutic drug for chronic orofacial pain
{{output}}
Background: Botulinum toxin type A (BTX-A), produced by the gram-positive anaerobic bacterium Clostridium botulinum, acts by cleaving synaptosome-associated protein-25 (SNAP-25), an essential component of the presynaptic neuronal... ...
